Literature DB >> 26190515

Morphology of the human cervical vagus nerve: implications for vagus nerve stimulation treatment.

T J M Verlinden1, K Rijkers2,3, G Hoogland2, A Herrler1.   

Abstract

OBJECTIVES: The vagus nerve has gained a role in the treatment of certain diseases by the use of vagus nerve stimulation (VNS). This study provides detailed morphological information regarding the human cervical vagus nerve at the level of electrode implant.
RESULTS: Eleven pairs of cervical vagus nerves and four pairs of intracranial vagus nerves were analysed by the use of computer software. It was found that the right cervical vagus nerve has an 1.5 times larger effective surface area on average than the left nerve [1,089,492 ± 98,337 vs 753,915 ± 102,490 μm(2), respectively, (P < 0.05)] and that there is broad spreading within the individual nerves. At the right side, the mean effective surface area at the cervical level (1,089,492 ± 98,337 μm(2)) is larger than at the level inside the skull base (630,921 ± 105,422) (P < 0.05). This could imply that the vagus nerve receives anastomosing and 'hitchhiking' branches from areas other than the brainstem. Furthermore, abundant tyrosine hydroxylase (TH)- and dopamine ß-hydroxylase (DBH)-positive staining nerve fibres could be identified, indicating catecholaminergic neurotransmission. In two of the 22 cervical nerves, ganglion cells were found that also stained positive for TH and DBH. Stimulating the vagus nerve may therefore induce the release of dopamine and noradrenaline. A sympathetic activation could therefore be part of mechanism of action of VNS. Furthermore, it was shown that the right cervical vagus nerve contains on average two times more TH-positive nerve fibres than the left nerve (P < 0.05), a fact that could be of interest upon choosing stimulation side. We also suggest that the amount of epineurial tissue could be an important variable for determining individual effectiveness of VNS, because the absolute amount of epineurial tissue is widely spread between the individual nerves (ranging from 2,090,000 to 11,683,000 μm(2)).
CONCLUSIONS: We conclude by stating that one has to look at the vagus nerve as a morphological entity of the peripheral autonomic nervous system, a composite of different fibres and (anastomosing and hitchhiking) branches of different origin with different neurotransmitters, which can act both parasympathetic and sympathetic. Electrically stimulating the vagus nerve therefore is not the same as elevating the 'physiological parasympathetic tone', but may also implement catecholaminergic (sympathetic) effects.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  dopamine ß-hydroxylase; morphology; morphometric analysis; osmium tetroxide; peripheral autonomic nervous system; tyrosine hydroxylase; vagus nerve stimulation

Mesh:

Substances:

Year:  2015        PMID: 26190515     DOI: 10.1111/ane.12462

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  36 in total

1.  From neuroimunomodulation to bioelectronic treatment of rheumatoid arthritis.

Authors:  Alexandre Kanashiro; Gabriel Shimizu Bassi; Fernando de Queiróz Cunha; Luis Ulloa
Journal:  Bioelectron Med (Lond)       Date:  2018-05

Review 2.  New approaches for treating atrial fibrillation: Focus on autonomic modulation.

Authors:  Daniel Sohinki; Stavros Stavrakis
Journal:  Trends Cardiovasc Med       Date:  2019-10-31       Impact factor: 6.677

3.  Optimization of the electrode drive pattern for imaging fascicular compound action potentials in peripheral nerve with fast neural electrical impedance tomography.

Authors:  Enrico Ravagli; Svetlana Mastitskaya; Nicole Thompson; Kirill Aristovich; David Holder
Journal:  Physiol Meas       Date:  2019-12-03       Impact factor: 2.833

4.  Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.

Authors:  Ariana Q Farrand; Kristi L Helke; Rebecca A Gregory; Monika Gooz; Vanessa K Hinson; Heather A Boger
Journal:  Brain Stimul       Date:  2017-08-24       Impact factor: 8.955

5.  Modulation of experimental arthritis by vagal sensory and central brain stimulation.

Authors:  Gabriel Shimizu Bassi; Daniel Penteado Martins Dias; Marcelo Franchin; Jhimmy Talbot; Daniel Gustavo Reis; Gustavo Batista Menezes; Jaci Airton Castania; Norberto Garcia-Cairasco; Leonardo Barbosa Moraes Resstel; Helio Cesar Salgado; Fernando Queiróz Cunha; Thiago Mattar Cunha; Luis Ulloa; Alexandre Kanashiro
Journal:  Brain Behav Immun       Date:  2017-04-06       Impact factor: 7.217

6.  TREAT AF (Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation): A Randomized Clinical Trial.

Authors:  Stavros Stavrakis; Julie A Stoner; Mary Beth Humphrey; Lynsie Morris; Adrian Filiberti; Justin C Reynolds; Khaled Elkholey; Isma Javed; Nicholas Twidale; Pavel Riha; Subha Varahan; Benjamin J Scherlag; Warren M Jackman; Tarun W Dasari; Sunny S Po
Journal:  JACC Clin Electrophysiol       Date:  2020-01-29

Review 7.  Bionic intrafascicular interfaces for recording and stimulating peripheral nerve fibers.

Authors:  Ranu Jung; James J Abbas; Sathyakumar Kuntaegowdanahalli; Anil K Thota
Journal:  Bioelectron Med (Lond)       Date:  2017-12-14

Review 8.  Cardiovascular autonomic effects of vagus nerve stimulation.

Authors:  Iñigo Garamendi-Ruiz; Juan Carlos Gómez-Esteban
Journal:  Clin Auton Res       Date:  2017-10-25       Impact factor: 4.435

Review 9.  Enhancing Rehabilitative Therapies with Vagus Nerve Stimulation.

Authors:  Seth A Hays
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

Review 10.  Vagus Nerve Stimulation at the Interface of Brain-Gut Interactions.

Authors:  Bruno Bonaz; Valérie Sinniger; Sonia Pellissier
Journal:  Cold Spring Harb Perspect Med       Date:  2019-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.